Researching the natural history of transfusion-transmitted infections: the UK hepatitis C (HCV) national register

2010 ◽  
pp. 323-328
Author(s):  
Helen Harris
Keyword(s):  
Hepatitis C ◽  
Natural History ◽  
National Register ◽  
History Of ◽  
The Uk

The HCV National Register: towards informing the natural history of hepatitis C infection in the UK

2000 ◽  
Vol 7 (6) ◽  
pp. 420-427 ◽  
Author(s):  
H. E. Harris ◽  
M. E. Ramsay ◽  
J. Heptonstall ◽  
K. Soldan ◽  
K. P. Eldridge ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Natural History ◽  
Hepatitis C Infection ◽  
National Register ◽  
History Of ◽  
The Uk

The Natural History of Hepatitis C Virus Infection in Hemophiliacs

Hematology ◽  
2001 ◽  
Vol 6 (2) ◽  
pp. 135-142 ◽  
Author(s):  
M. Franchini ◽  
A. Tagliaferri ◽  
G. Rossetti ◽  
F. Capra ◽  
E. De Maria ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Natural History ◽  
Virus Infection ◽  
Hepatitis C Virus Infection ◽  
History Of

scholarly journals Natural History of Hepatitis C Virus among Apparently Normal Schoolchildren: Follow‐up after 7 Years

2003 ◽  
Vol 49 (6) ◽  
pp. 384-385 ◽  
Author(s):  
Azza El‐Sherbini ◽  
Wafaa Hassan ◽  
Mohamad Abdel‐Hamid ◽  
Ahmad Naeim
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Natural History ◽  
History Of

Hepatitis C and HIV Co-Infection

2017 ◽  
Author(s):  
Jennifer Cohen Price ◽  
Priyanka Amin ◽  
Antoine Douaihy
Keyword(s):  
Hepatitis C ◽  
Natural History ◽  
The United States ◽  
Hcv Infection ◽  
Hepatic Decompensation ◽  
History Of ◽  
Chronic Hcv ◽  
Direct Acting ◽  
End Stage ◽  
Shared Risk

Chronic infection with hepatitis C virus (HCV) is a leading cause of end-stage liver disease and is the most common indication for liver transplantation in the United States. Because of shared risk factors, individuals living with HIV infection are disproportionately affected by HCV. Moreover, co-infection with HIV accelerates the natural history of chronic HCV infection, increasing the risk of cirrhosis, hepatocellular carcinoma, hepatic decompensation, and death. Highly effective medications such as direct-acting antivirals (DAA) to cure HCV are now available and have the potential to profoundly improve the health of HIV-HCV-co-infected individuals. However, addressing the many gaps in the HCV care cascade is necessary to fully achieve the benefits of these drugs. This chapter reviews the natural history of HIV-HCV co-infection, the psychiatric comorbidities associated with HCV infection, the evolution of HCV treatment, and the barriers to care that HIV-HCV-co-infected individuals continue to face.

Sign in / Sign up

Export Citation Format

Share Document